Patents Assigned to PHERECYDES PHARMA
  • Phage therapy
    Patent number: 11779617
    Abstract: The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Pseudomonas aeruginosa strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: October 10, 2023
    Assignee: PHERECYDES PHARMA
    Inventors: Flavie Pouillot, Helene Blois
  • Anti-bacterial compositions and uses thereof
    Patent number: 11690885
    Abstract: The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Staphylococcus aureus strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy and as companion diagnostic.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: July 4, 2023
    Assignee: PHERECYDES PHARMA
    Inventors: Cindy Fevre, Hélène Blois, Mathieu Medina
  • Phage therapy of infections
    Patent number: 10918680
    Abstract: The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Escherichia coli strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: February 16, 2021
    Assignee: PHERECYDES PHARMA
    Inventors: Flavie Pouillot, Hélène Blois
  • Phage therapy
    Patent number: 10898530
    Abstract: The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Pseudomonas aeruginosa strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: January 26, 2021
    Assignee: PHERECYDES PHARMA
    Inventors: Flavie Pouillot, Helene Blois
  • Phage therapy of infections
    Patent number: 10260051
    Abstract: The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Pseudomonas aeruginosa strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: April 16, 2019
    Assignee: PHERECYDES PHARMA
    Inventors: Flavie Pouillot, Helene Blois
  • Phage therapy of pseudomonas infections
    Patent number: 10077431
    Abstract: The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Pseudomonas aeruginosa strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.
    Type: Grant
    Filed: October 24, 2014
    Date of Patent: September 18, 2018
    Assignee: PHERECYDES PHARMA
    Inventors: Flavie Pouillot, Hélène Blois
  • Method for the preparation of modified bacteriophages by insertion of random sequences in the targeting proteins of said bacteriophages
    Patent number: 9315803
    Abstract: The invention relates to a method for obtaining a variety of recombinant bacteriophages in which the screening proteins have been modified by the insertion in their genetic sequence of randomly produced oligonucleotides, and to bacteriophages banks that can be obtained according to said method.
    Type: Grant
    Filed: December 18, 2007
    Date of Patent: April 19, 2016
    Assignee: PHERECYDES PHARMA
    Inventor: François Iris
  • Modification of the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof
    Patent number: 9029153
    Abstract: The present invention relates to a method for the reversible immobilization of lytic bacteriophages within their modified bacterial hosts. It relates more particularly to a method for modifying the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: May 12, 2015
    Assignee: Pherecydes Pharma
    Inventors: Flavie Pouillot, Francois Iris
  • Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence
    Patent number: 8728734
    Abstract: The invention relates to a very general method for the random diversification of a nucleotide sequence S by PCR while preserving the identity of some domains of said sequence S; the invention also relates to a bank of nucleotide sequence thus diversified, and to diversified proteins obtained by the expressions of the nucleotide sequences in an appropriate host.
    Type: Grant
    Filed: December 18, 2007
    Date of Patent: May 20, 2014
    Assignee: Pherecydes Pharma
    Inventor: Francois Iris
  • MODIFICATION OF THE GENOME OF A LYTIC BACTERIOPHAGE BY IMMOBILIZING SAID BACTERIOPHAGE IN THE HOST BACTERIUM THEREOF
    Publication number: 20120040465
    Abstract: The present invention relates to a method for the reversible immobilization of lytic bacteriophages within their modified bacterial hosts. It relates more particularly to a method for modifying the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof.
    Type: Application
    Filed: April 27, 2010
    Publication date: February 16, 2012
    Applicant: PHERECYDES PHARMA
    Inventors: Flavie Pouillot, Francois Iris
  • Method for the Random Diversification of a Genetic Sequence While Preserving the Identity of Some Inner Segments of said Genetic Sequence
    Publication number: 20110053801
    Abstract: The invention relates to a very general method for the random diversification of a nucleotide sequence S by PCR while preserving the identity of some domains of said sequence S; the invention also relates to a bank of nucleotide sequence thus diversified, and to diversified proteins obtained by the expressions of the nucleotide sequences in an appropriate host.
    Type: Application
    Filed: December 18, 2007
    Publication date: March 3, 2011
    Applicant: PHERECYDES PHARMA
    Inventor: Francois Iris
  • METHOD FOR THE RANDOM DIVERSIFICATION OF A GENETIC SEQUENCE WHILE PRESERVING THE IDENTITY OF SOME INNER SEGMENTS OF SAID GENETIC SEQUENCE
    Publication number: 20110027231
    Abstract: The invention relates to a method for obtaining a variety of recombinant bacteriophages in which the screening proteins have been modified by the insertion in their genetic sequence of randomly produced oligonucleotides, and to bacteriophages banks that can be obtained according to said method.
    Type: Application
    Filed: December 18, 2007
    Publication date: February 3, 2011
    Applicant: PHERECYDES PHARMA
    Inventor: François Iris